Zhongnan Medical Journal Press

Home Results

A total of 18 result was found. Results that relate to LI Bin

Establishment of predictive model for cardiovascular complication of diabetes mellitus

Published on New Medicine 2024,34(1):2-13.
16462 times 3319 times

SUN Yuan1 LIU Kuo1 LI Bingxiao1 WEN Fuyuan1 LI Pandi1 YANG Xiaojun1 QU Aibin1 ZHANG Ling1

Diabetes Cardiovascular complication Lasso regression Predictive model
Details
Mining pharmacovigilance signals for asthma adverse events in underage population based on the FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(1):28-36.
11790 times 2745 times

CHEN Yan LI Bing LIU Xia LIU Hongyan SHAN Qing GUO Jinmin

Asthma Underage population FAERS database Data mining Pharmacovigilance
Details
Data mining of hematological adverse events related to antibody-drug conjugate based on FAERS

Published on Chinese Journal of Pharmacoepidemiology 2024,33(2):158-165.
13321 times 2864 times

DENG Huijie LIU Xia LI Bing SHAN Qing CHEN Yan GUO Yuhang GUO Jinmin

Antibody drug conjugates Hematological adverse events FAERS database Data mining Report ratio ratio method Information component method Pharmacovigilance
Details
Definition and literature of evidence-based urology: a systematic review

Published on New Medicine 2024,34(7):725-743.
13784 times 2955 times

WANG Yunyun CHEN Zheng ZHONG Quliang HUANG Xing XU Xiaofeng LI Xiaodong ZI Hao JIN Yinghui LI Binghui WENG Hong DONG Zhilong ZENG Xiantao

Evidence-based medicine Evidence-based urology Definition Methodology Systematic review
Details
Signal mining and analysis of adverse drug events related to trastuzumab emtansine and trastuzumab deruxtecan based on JADER database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(8):841-850.
13097 times 3006 times

PAN Weiping YAN Shaowei LI Binghuang CAO Yu XU Wentan

Trastuzumab emtansine Trastuzumab deruxtecan Adverse drug event JADER database Pharmacovigilance Antibody-drug conjugates
Details
An analysis of disease burden and risk factors of chronic kidney disease in China from 1990 to 2021

Published on New Medicine 2024,34(9):957-969.
34301 times 5224 times

QIN Lihong CHEN Jing XIANG Yadie LI Binghui LUO Lisha CHEN Ling

Chronic kidney disease Disease burden Disability-adjusted life years Trends Risk factors
Details
Clinical pharmacists participated in the drug therapy and pharmaceutical care of a patient with Crohn's disease complicated with erythema multiforme

Published on Chinese Journal of Pharmacoepidemiology 2024,33(9):1074-1080.
15005 times 2732 times

LI Binbin XU Cuilin HU Naizhong REN Xiaofei WANG Yanyan

Crohn's disease Erythema multiforme Infliximab Ustekinumab Extraintestinal manifestations Pharmaceutical care
Details
Signal mining for cutaneous adverse events associated with antibody-drug conjugates based on FAERS database

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1091-1098.
12089 times 2735 times

QIAN Mengying ZHANG Yongyi SHAN Qing CHEN Yan LI Bing GUO Jinmin

Antibody-drug conjugate Cutaneous adverse event FAERS database Data mining Pharmacovigilance
Details
The effect of applying Bloom’s taxonomy theory of education in the teaching of evidence-based medicine curriculum for undergraduates

Published on New Medicine 2024,34(10):1183-1190.
13052 times 2945 times

WANG Yunyun YUAN Shuai WANG Yu LI Binghui FANG Cheng ZHANG Yuanyuan HUANG Jiao ZENG Xiantao

Bloom's taxonomy of educational objective Evidence-based medicine Teaching reform Application effect Teaching satisfaction
Details
Analysis of the clinical effect of intracoronary injection of recombinant human prourokinase on emergency percutaneous coronary intervention

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1209-1218.
13866 times 2636 times

ZHENG Heng GAN Shouyi FU Jing LI Bin

Acute ST segment elevation myocardial infarction Emergency PCI Recombinant human prourokinase Clinical effect
Details
Bibliometric analysis and reflections on the current status of traditional Chinese medicine systematic reviews and Meta-analysis in the past decade

Published on Chinese Journal of Pharmacoepidemiology 2025,34(1):57-68.
24014 times 3533 times

WANG Jiaying ZHAO Yi DUAN Ru LIU Jingting WU Yun ZHANG Jisheng XIANG Xuemei GU Yifei TIAN Yu CAO Yawen LI Bin WANG Xianliang MAO Jingyuan

Traditional Chinese medicine Systematic review Meta-analysis Bibliometrics Current status survey
Details
Current status analysis of anti-infection research by using the Bayesian method

Published on Chinese Journal of Pharmacoepidemiology 2025,34(1):69-77.
12893 times 2435 times

LIU Yiling LIU Jinglin LU Zhenzhen WANG Yingying JIANG Qijing LI Bingzhe DAI Luyan YAN Fanrong HUANG Lihong

Bayesian method Anti-infection research Research features
Details
Animal pharmacokinetics and pharmacodynamics of novel receptor-interacting protein kinase 1 inhibitors

Published on Frontiers in Pharmaceutical Sciences 2025,29(1):82-90.
12054 times 1699 times

ZHOU Haimeng LI Bin WANG Guozheng CHEN Shizhu ZHAO Xin XU Wenjuan DONG Ling

RIP1 kinases inhibitors Necrosis Pharmacokinetics Pharmacology
Details
A case report of ischemic bowel disease caused by Shengxuexiaoban capsules

Published on Chinese Journal of Pharmacoepidemiology 2025,34(2):236-240.
13145 times 2423 times

XU Cuilin LI Binbin HU Jing HU Naizhong WANG Yanyan

Shengxuexiaoban capsules Ischemic bowel disease Adverse reactions
Details
KAP investigation and influential factor analysis on the risk of medication safety behavior among cancer patients in western Yunnan

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1049-1056.
8536 times 1961 times

QUE Suyun MA Qiaoling ZHOU Xia CUN Yufang LI Bin XU Shidong MA Xi'na

Medication safety Behavioral risk Knowledge-attitude-behavior Oncology patients Factors affecting
Details